The Scientist

» FDA and microbiology

Most Recent

image: Gut Bugs Affect Cockroach Poop-ularity

Gut Bugs Affect Cockroach Poop-ularity

By | December 9, 2015

Commensal bacteria living in the gastrointestinal tracts of cockroaches lace the insects’ feces with chemical cues that mediate social behavior, according to a study.

1 Comment

image: Metformin Users Have Different Gut Bugs

Metformin Users Have Different Gut Bugs

By | December 6, 2015

The popular type 2 diabetes drug may cause profound changes in patients’ microbiomes.

0 Comments

image: Fatal-Disease Drug in Limbo

Fatal-Disease Drug in Limbo

By | November 25, 2015

A panel of experts advised the US Food and Drug Administration that BioMarin Pharmaceutical has not demonstrated efficacy of its new drug for Duchenne muscular dystrophy.

0 Comments

image: Agar Shortage Limits Lab Supplies

Agar Shortage Limits Lab Supplies

By | November 24, 2015

One large provider says the shortfall should clear up by early 2016.

1 Comment

image: FDA OKs GM Salmon

FDA OKs GM Salmon

By | November 19, 2015

AquaBounty Technologies’s fast-growing fish is the first genetically modified animal approved by the US Food and Drug Administration.

0 Comments

image: FDA: Lab Tests Can Cause Harm

FDA: Lab Tests Can Cause Harm

By | November 17, 2015

The US Food and Drug Administration cites cases in which laboratory-developed tests “may have caused or have caused actual harm to patients.”

1 Comment

image: Clinical Trial Data Underreported: Study

Clinical Trial Data Underreported: Study

By | November 16, 2015

One-third of the human experiments for approved drugs failed transparency requirements.

0 Comments

image: Blood-Gut Barrier

Blood-Gut Barrier

By | November 12, 2015

Scientists identify a barrier in mice between the intestine and its blood supply, and suggest how Salmonella sneaks through it.

0 Comments

image: Exploring the Inner Universe

Exploring the Inner Universe

By | November 6, 2015

A new American Museum of Natural History exhibit introduces visitors to the microbes within their bodies. 

0 Comments

image: Battling the Bulge

Battling the Bulge

By | November 1, 2015

Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech